APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oral Live Cholera Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral Live Cholera Vaccines Industry Growth and Trends Forecast to 2032

Report ID 174019950122 December 202594 pages

Choose your research edition.

Industry ResearchOral Live Cholera Vaccines Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Live Cholera Vaccines Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Oral Live Cholera Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Live Cholera Vaccines Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Live Cholera Vaccines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Oral Live Cholera Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral Live Cholera Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral Live Cholera Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Live Cholera Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Live Cholera Vaccines include Shanghai United Cell Biotechnology, Sanofi, Valneva, Vabiotech, PaxVax and EuBiologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral Live Cholera Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral Live Cholera Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Live Cholera Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Live Cholera Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral Live Cholera Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral Live Cholera Vaccines Market by Company

Shanghai United Cell Biotechnology

Sanofi

Valneva

Vabiotech

PaxVax

EuBiologics

Oral Live Cholera Vaccines Segment by Type

Shanchol

Euvichol- Plus

DUKORAL

Others

Oral Live Cholera Vaccines Segment by Application

Prevention

Emergency Response

Oral Live Cholera Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Live Cholera Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Live Cholera Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Live Cholera Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Live Cholera Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral Live Cholera Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Shanchol Table 2. Major Company of Euvichol- Plus Table 3. Major Company of DUKORAL Table 4. Major Company of Others Table 5. Global Oral Live Cholera Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Oral Live Cholera Vaccines Sales by Type (2021-2026) & (k units) Table 7. Global Oral Live Cholera Vaccines Sales Market Share in Volume by Type (2021-2026) Table 8. Global Oral Live Cholera Vaccines Sales by Type (2021-2026) & (US$ Million) Table 9. Global Oral Live Cholera Vaccines Sales Market Share in Value by Type (2021-2026) Table 10. Global Oral Live Cholera Vaccines Price by Type (2021-2026) & (US$/unit) Table 11. Global Oral Live Cholera Vaccines Sales by Type (2027-2032) & (k units) Table 12. Global Oral Live Cholera Vaccines Sales Market Share in Volume by Type (2027-2032) Table 13. Global Oral Live Cholera Vaccines Sales by Type (2027-2032) & (US$ Million) Table 14. Global Oral Live Cholera Vaccines Sales Market Share in Value by Type (2027-2032) Table 15. Global Oral Live Cholera Vaccines Price by Type (2027-2032) & (US$/unit) Table 16. North America Oral Live Cholera Vaccines Sales by Type (2021-2026) & (k units) Table 17. North America Oral Live Cholera Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Oral Live Cholera Vaccines Sales by Type (2021-2026) & (k units) Table 19. Europe Oral Live Cholera Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Oral Live Cholera Vaccines Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Oral Live Cholera Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Oral Live Cholera Vaccines Sales by Type (2021-2026) & (k units) Table 23. Latin America Oral Live Cholera Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Oral Live Cholera Vaccines Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Oral Live Cholera Vaccines Sales by Type (2021-2026) & (US$ Million) Table 26. Oral Live Cholera Vaccines Industry Trends Table 27. Oral Live Cholera Vaccines Industry Drivers Table 28. Oral Live Cholera Vaccines Industry Opportunities and Challenges Table 29. Oral Live Cholera Vaccines Industry Restraints Table 30. Global Oral Live Cholera Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Oral Live Cholera Vaccines Revenue Market Share by Company (2021-2026) Table 32. Global Oral Live Cholera Vaccines Sales by Company (2021-2026) & (k units) Table 33. Global Oral Live Cholera Vaccines Sales Share by Company (2021-2026) Table 34. Global Oral Live Cholera Vaccines Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Oral Live Cholera Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Oral Live Cholera Vaccines Major Company Production Sites and Headquarters Table 37. Global Oral Live Cholera Vaccines Company, Product Type & Application Table 38. Global Oral Live Cholera Vaccines Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Oral Live Cholera Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Oral Live Cholera Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Oral Live Cholera Vaccines Sales by Region (2021-2026) & (k units) Table 43. Global Oral Live Cholera Vaccines Sales Market Share in Volume by Region (2021-2026) Table 44. Global Oral Live Cholera Vaccines Sales by Region (2021-2026) & (US$ Million) Table 45. Global Oral Live Cholera Vaccines Sales Market Share in Value by Region (2021-2026) Table 46. Global Oral Live Cholera Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Oral Live Cholera Vaccines Sales by Region (2027-2032) & (k units) Table 48. Global Oral Live Cholera Vaccines Sales Market Share in Volume by Region (2027-2032) Table 49. Global Oral Live Cholera Vaccines Sales by Region (2027-2032) & (US$ Million) Table 50. Global Oral Live Cholera Vaccines Sales Market Share in Value by Region (2027-2032) Table 51. Global Oral Live Cholera Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Oral Live Cholera Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Oral Live Cholera Vaccines Sales by Application (2021-2026) & (k units) Table 54. Global Oral Live Cholera Vaccines Sales Market Share in Volume by Application (2021-2026) Table 55. Global Oral Live Cholera Vaccines Sales by Application (2021-2026) & (US$ Million) Table 56. Global Oral Live Cholera Vaccines Sales Market Share in Value by Application (2021-2026) Table 57. Global Oral Live Cholera Vaccines Price by Application (2021-2026) & (US$/unit) Table 58. Global Oral Live Cholera Vaccines Sales by Application (2027-2032) & (k units) Table 59. Global Oral Live Cholera Vaccines Sales Market Share in Volume by Application (2027-2032) Table 60. Global Oral Live Cholera Vaccines Sales by Application (2027-2032) & (US$ Million) Table 61. Global Oral Live Cholera Vaccines Sales Market Share in Value by Application (2027-2032) Table 62. Global Oral Live Cholera Vaccines Price by Application (2027-2032) & (US$/unit) Table 63. North America Oral Live Cholera Vaccines Sales by Application (2021-2026) & (k units) Table 64. North America Oral Live Cholera Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Oral Live Cholera Vaccines Sales by Application (2021-2026) & (k units) Table 66. Europe Oral Live Cholera Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Oral Live Cholera Vaccines Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Oral Live Cholera Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Oral Live Cholera Vaccines Sales by Application (2021-2026) & (k units) Table 70. Latin America Oral Live Cholera Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Oral Live Cholera Vaccines Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Oral Live Cholera Vaccines Sales by Application (2021-2026) & (US$ Million) Table 73. Shanghai United Cell Biotechnology Company Information Table 74. Shanghai United Cell Biotechnology Business Overview Table 75. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product Portfolio Table 77. Shanghai United Cell Biotechnology Recent Development Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Oral Live Cholera Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Sanofi Oral Live Cholera Vaccines Product Portfolio Table 82. Sanofi Recent Development Table 83. Valneva Company Information Table 84. Valneva Business Overview Table 85. Valneva Oral Live Cholera Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Valneva Oral Live Cholera Vaccines Product Portfolio Table 87. Valneva Recent Development Table 88. Vabiotech Company Information Table 89. Vabiotech Business Overview Table 90. Vabiotech Oral Live Cholera Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Vabiotech Oral Live Cholera Vaccines Product Portfolio Table 92. Vabiotech Recent Development Table 93. PaxVax Company Information Table 94. PaxVax Business Overview Table 95. PaxVax Oral Live Cholera Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. PaxVax Oral Live Cholera Vaccines Product Portfolio Table 97. PaxVax Recent Development Table 98. EuBiologics Company Information Table 99. EuBiologics Business Overview Table 100. EuBiologics Oral Live Cholera Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. EuBiologics Oral Live Cholera Vaccines Product Portfolio Table 102. EuBiologics Recent Development Table 103. North America Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 104. North America Oral Live Cholera Vaccines Sales by Country (2021-2026) & (k units) Table 105. North America Oral Live Cholera Vaccines Sales Market Share by Country (2021-2026) Table 106. North America Oral Live Cholera Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 107. North America Oral Live Cholera Vaccines Sales Market Share Forecast by Country (2027-2032) Table 108. North America Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Oral Live Cholera Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Oral Live Cholera Vaccines Market Share by Country (2021-2026) Table 111. North America Oral Live Cholera Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Oral Live Cholera Vaccines Market Share Forecast by Country (2027-2032) Table 113. Europe Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 114. Europe Oral Live Cholera Vaccines Sales by Country (2021-2026) & (k units) Table 115. Europe Oral Live Cholera Vaccines Sales Market Share by Country (2021-2026) Table 116. Europe Oral Live Cholera Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 117. Europe Oral Live Cholera Vaccines Sales Market Share Forecast by Country (2027-2032) Table 118. Europe Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Oral Live Cholera Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Oral Live Cholera Vaccines Market Share by Country (2021-2026) Table 121. Europe Oral Live Cholera Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Oral Live Cholera Vaccines Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Oral Live Cholera Vaccines Sales by Country (2021-2026) & (k units) Table 125. Asia-Pacific Oral Live Cholera Vaccines Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific Oral Live Cholera Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 127. Asia-Pacific Oral Live Cholera Vaccines Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Oral Live Cholera Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Oral Live Cholera Vaccines Market Share by Country (2021-2026) Table 131. Asia-Pacific Oral Live Cholera Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Oral Live Cholera Vaccines Market Share Forecast by Country (2027-2032) Table 133. Latin America Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. Latin America Oral Live Cholera Vaccines Sales by Country (2021-2026) & (k units) Table 135. Latin America Oral Live Cholera Vaccines Sales Market Share by Country (2021-2026) Table 136. Latin America Oral Live Cholera Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 137. Latin America Oral Live Cholera Vaccines Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Oral Live Cholera Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Oral Live Cholera Vaccines Market Share by Country (2021-2026) Table 141. Latin America Oral Live Cholera Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Oral Live Cholera Vaccines Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Oral Live Cholera Vaccines Sales by Country (2021-2026) & (k units) Table 145. Middle East and Africa Oral Live Cholera Vaccines Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa Oral Live Cholera Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 147. Middle East and Africa Oral Live Cholera Vaccines Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Oral Live Cholera Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa Oral Live Cholera Vaccines Market Share by Country (2021-2026) Table 151. Middle East and Africa Oral Live Cholera Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Oral Live Cholera Vaccines Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Oral Live Cholera Vaccines Distributors List Table 156. Oral Live Cholera Vaccines Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Oral Live Cholera Vaccines Image Figure 2. Global Oral Live Cholera Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Live Cholera Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Live Cholera Vaccines Sales (2021-2032) & (k units) Figure 5. Shanchol Image Figure 6. Global Shanchol Sales YoY Growth (2021-2032) & (k units) Figure 7. Euvichol- Plus Image Figure 8. Global Euvichol- Plus Sales YoY Growth (2021-2032) & (k units) Figure 9. DUKORAL Image Figure 10. Global DUKORAL Sales YoY Growth (2021-2032) & (k units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Oral Live Cholera Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Oral Live Cholera Vaccines Market Share by Type 2025 VS 2032 Figure 15. North America Oral Live Cholera Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. North America Oral Live Cholera Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Europe Oral Live Cholera Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Europe Oral Live Cholera Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Oral Live Cholera Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Oral Live Cholera Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Latin America Oral Live Cholera Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Oral Live Cholera Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Oral Live Cholera Vaccines Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Oral Live Cholera Vaccines Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Oral Live Cholera Vaccines Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Prevention Image Figure 28. Global Prevention Sales YoY Growth (2021-2032) & (k units) Figure 29. Emergency Response Image Figure 30. Global Emergency Response Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Oral Live Cholera Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Oral Live Cholera Vaccines Market Share by Application 2025 VS 2032 Figure 33. North America Oral Live Cholera Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. North America Oral Live Cholera Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Europe Oral Live Cholera Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Europe Oral Live Cholera Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Oral Live Cholera Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Oral Live Cholera Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Latin America Oral Live Cholera Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Oral Live Cholera Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Oral Live Cholera Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Oral Live Cholera Vaccines Sales Market Share in Value by Application in 2025 Figure 43. North America Oral Live Cholera Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Oral Live Cholera Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Oral Live Cholera Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Oral Live Cholera Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Oral Live Cholera Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Oral Live Cholera Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Oral Live Cholera Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Oral Live Cholera Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Oral Live Cholera Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Oral Live Cholera Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Oral Live Cholera Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Oral Live Cholera Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Oral Live Cholera Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Oral Live Cholera Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Oral Live Cholera Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Oral Live Cholera Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Oral Live Cholera Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Oral Live Cholera Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Oral Live Cholera Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Oral Live Cholera Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Oral Live Cholera Vaccines Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Oral Live Cholera Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Shanchol
  • Euvichol- Plus
  • DUKORAL
  • Others
Applications
  • Prevention
  • Emergency Response
Companies covered
  • Shanghai United Cell Biotechnology
  • Sanofi
  • Valneva
  • Vabiotech
  • PaxVax
  • EuBiologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Live Cholera Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral Live Cholera Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral Live Cholera Vaccines Market by Type
  6. 1.3.1 Shanchol
  7. 1.3.2 Euvichol- Plus
  8. 1.3.3 DUKORAL
  9. 1.3.4 Others
  10. 1.4 Global Oral Live Cholera Vaccines Market Size by Type
  11. 1.4.1 Global Oral Live Cholera Vaccines Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Oral Live Cholera Vaccines Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Oral Live Cholera Vaccines Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Oral Live Cholera Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Oral Live Cholera Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Oral Live Cholera Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Oral Live Cholera Vaccines Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Oral Live Cholera Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral Live Cholera Vaccines Industry Trends
  2. 2.2 Oral Live Cholera Vaccines Industry Drivers
  3. 2.3 Oral Live Cholera Vaccines Industry Opportunities and Challenges
  4. 2.4 Oral Live Cholera Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral Live Cholera Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral Live Cholera Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Oral Live Cholera Vaccines Price (2021-2026)
  4. 3.4 Global Oral Live Cholera Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Live Cholera Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Oral Live Cholera Vaccines Company, Product Type & Application
  7. 3.7 Global Oral Live Cholera Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Live Cholera Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Live Cholera Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Live Cholera Vaccines Tier 1, Tier 2, and Tier 3
4 Oral Live Cholera Vaccines Regional Status and Outlook
  1. 4.1 Global Oral Live Cholera Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral Live Cholera Vaccines Historic Market Size by Region
  3. 4.2.1 Global Oral Live Cholera Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral Live Cholera Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral Live Cholera Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral Live Cholera Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Oral Live Cholera Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral Live Cholera Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral Live Cholera Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Live Cholera Vaccines by Application
  1. 5.1 Oral Live Cholera Vaccines Market by Application
  2. 5.1.1 Prevention
  3. 5.1.2 Emergency Response
  4. 5.2 Global Oral Live Cholera Vaccines Market Size by Application
  5. 5.2.1 Global Oral Live Cholera Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Oral Live Cholera Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Oral Live Cholera Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Oral Live Cholera Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Oral Live Cholera Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Oral Live Cholera Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Oral Live Cholera Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Oral Live Cholera Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shanghai United Cell Biotechnology
  2. 6.1.1 Shanghai United Cell Biotechnology Company Information
  3. 6.1.2 Shanghai United Cell Biotechnology Business Overview
  4. 6.1.3 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product Portfolio
  6. 6.1.5 Shanghai United Cell Biotechnology Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Oral Live Cholera Vaccines Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Valneva
  14. 6.3.1 Valneva Company Information
  15. 6.3.2 Valneva Business Overview
  16. 6.3.3 Valneva Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Valneva Oral Live Cholera Vaccines Product Portfolio
  18. 6.3.5 Valneva Recent Developments
  19. 6.4 Vabiotech
  20. 6.4.1 Vabiotech Company Information
  21. 6.4.2 Vabiotech Business Overview
  22. 6.4.3 Vabiotech Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Vabiotech Oral Live Cholera Vaccines Product Portfolio
  24. 6.4.5 Vabiotech Recent Developments
  25. 6.5 PaxVax
  26. 6.5.1 PaxVax Company Information
  27. 6.5.2 PaxVax Business Overview
  28. 6.5.3 PaxVax Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 PaxVax Oral Live Cholera Vaccines Product Portfolio
  30. 6.5.5 PaxVax Recent Developments
  31. 6.6 EuBiologics
  32. 6.6.1 EuBiologics Company Information
  33. 6.6.2 EuBiologics Business Overview
  34. 6.6.3 EuBiologics Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 EuBiologics Oral Live Cholera Vaccines Product Portfolio
  36. 6.6.5 EuBiologics Recent Developments
7 North America by Country
  1. 7.1 North America Oral Live Cholera Vaccines Sales by Country
  2. 7.1.1 North America Oral Live Cholera Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral Live Cholera Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Oral Live Cholera Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral Live Cholera Vaccines Market Size by Country
  6. 7.2.1 North America Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral Live Cholera Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral Live Cholera Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral Live Cholera Vaccines Sales by Country
  2. 8.1.1 Europe Oral Live Cholera Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral Live Cholera Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral Live Cholera Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral Live Cholera Vaccines Market Size by Country
  6. 8.2.1 Europe Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral Live Cholera Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral Live Cholera Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral Live Cholera Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Oral Live Cholera Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral Live Cholera Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral Live Cholera Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral Live Cholera Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral Live Cholera Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral Live Cholera Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral Live Cholera Vaccines Sales by Country
  2. 10.1.1 South America Oral Live Cholera Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral Live Cholera Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Oral Live Cholera Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral Live Cholera Vaccines Market Size by Country
  6. 10.2.1 South America Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral Live Cholera Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral Live Cholera Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral Live Cholera Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Oral Live Cholera Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral Live Cholera Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral Live Cholera Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral Live Cholera Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral Live Cholera Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral Live Cholera Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral Live Cholera Vaccines Value Chain Analysis
  2. 12.1.1 Oral Live Cholera Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral Live Cholera Vaccines Production Mode & Process
  7. 12.2 Oral Live Cholera Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral Live Cholera Vaccines Distributors
  10. 12.2.3 Oral Live Cholera Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst